First Time Loading...

Progenity Inc
NASDAQ:PROG

Watchlist Manager
Progenity Inc Logo
Progenity Inc
NASDAQ:PROG
Watchlist
Price: 0.69 USD 0.01% Market Closed
Updated: May 15, 2024

Progenity Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Progenity Inc
Research & Development Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Progenity Inc
NASDAQ:PROG
Research & Development
-$45.8m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Progenity Inc's Research & Development?
Research & Development
-45.8m USD

Based on the financial report for Dec 31, 2021, Progenity Inc's Research & Development amounts to -45.8m USD.

What is Progenity Inc's Research & Development growth rate?
Research & Development CAGR 3Y
2%

Over the last year, the Research & Development growth was 4%. The average annual Research & Development growth rates for Progenity Inc have been 2% over the past three years .